Skip to content
December 03, 2022

Equity.Guru

Investment information for the new generation

NEON.C

The psychedelics space is loaded with over-valued unicorns and also-rans, making it difficult for investors to find real growth opportunities. Here are some companies in the sector that have…
Looking at the charts of the Psychedelics sector, they can best be described as a mixed bag. Just like Cannabis, shroom stocks are taking a hit. This could just…
In this episode, we take a look at 3 Canadian psychedelic stocks with potential: MYND Life Science (MYND.C), Mind Cure Health Inc. (MCUR.C), NeonMind Biosciences (NEON.C). We briefly go…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Whether you’re curious about taking a psychedelics investment trip or a tie-dyed-in-the-wool public market backer, psychedelics conferences are the best way to keep on top of industry advances and…
Another busy week in the psychedelic sector, with many smaller companies not always covered here at Equity Guru making news. Let’s start with the biggest players though. Mind Medicine…
NeonMind Biosciences (NEON.C) announced that they have received approval from Health Canada on the product license application for their ‘Mindful Blend’ functional mushroom product. The Mindful Blend functional mushroom…